Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-05-14 23:39 | 2012-05-11 | CVS | CVS HEALTH Corp | SGARRO DOUGLAS A | Officer; EVP and CLO | Retail-Drug Stores and Proprietary Stores | OPT+S | $46.17 | 35,043 | $1,618,086 | 214 | -99.4% |
| 2012-05-07 23:45 | 2012-05-03 | CVS | CVS HEALTH Corp | SGARRO DOUGLAS A | Officer; EVP and CLO | Retail-Drug Stores and Proprietary Stores | OPT+S | $46.19 | 137,930 | $6,370,407 | 214 | -99.8% |
| 2012-04-04 23:59 | 2012-04-02 | CVS | CVS HEALTH Corp | SGARRO DOUGLAS A | Officer; EVP and CLO | Retail-Drug Stores and Proprietary Stores | OPT+S | $44.95 | 136,912 | $6,154,140 | 214 | -99.8% |
| 2012-03-15 23:54 | 2012-03-13 | CVS | CVS HEALTH Corp | SGARRO DOUGLAS A | Officer; EVP and CLO | Retail-Drug Stores and Proprietary Stores | OPT+S | $44.99 | 654,941 | $29,465,403 | 214 | -100.0% |
| 2009-08-20 23:29 | 2009-08-18 | CVS | CVS HEALTH Corp | SGARRO DOUGLAS A | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $34.51 | 381,226 | $13,155,118 | 169,728 | -69.2% |
| 2008-09-11 23:54 | 2008-09-09 | CVS | CVS HEALTH Corp | SGARRO DOUGLAS A | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $38.02 | 100,000 | $3,802,090 | 127,549 | -43.9% |
| 2007-05-14 23:13 | 2007-05-11 | CVS | CVS HEALTH Corp | SGARRO DOUGLAS A | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $37.49 | 140,460 | $5,266,506 | 112,246 | -55.6% |
| 2004-11-11 00:49 | 2004-11-10 | CVS | CVS HEALTH Corp | SGARRO DOUGLAS A | Officer; Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $46.56 | 45,814 | $2,133,109 | 2,973 | -93.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.